Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
Emerg Infect Dis
; 23(10)2017 10.
Article
em En
| MEDLINE
| ID: mdl-28758888
ABSTRACT
We report the experiences of 5 patients taking bedaquiline with delamanid in combination 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 died from respiratory insufficiency. For 2 patients, QT-interval prolongation but no arrhythmias occurred. Use of this therapy is justified for patients with limited options.
Palavras-chave
Europe; India; Italy; MDR TB; Mycobacterium tuberculosis; Russia; Switzerland; TB; United Kingdom; XDR TB; antimicrobial resistance; bacteria; bedaquiline; combination treatment; delamanid; effectiveness; multidrug resistance; multidrug-resistant tuberculosis; mycobacteria; pulmonary; respiratory infections; safety; the Netherlands; tolerability; tuberculosis
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxazóis
/
Tuberculose Pulmonar
/
Tuberculose Extensivamente Resistente a Medicamentos
/
Diarilquinolinas
/
Nitroimidazóis
/
Antituberculosos
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article